PhRMA Foundation 2026 Drug Discovery, Delivery, and Translational Medicine Fellowships and Grants

MODERATE Tx Neuropharm/CCT

Strategy Notes

Strong sector fit: computational pharmacology, drug delivery platforms (TOPOLOGIX, IMPRINT), and addiction research align directly with PhRMA scope. Career stage matches (early-career, pre-PhD independent researcher). Funding range (~$72K) within applicant's $10K–$100K target. Major uncertainty: US-based foundation with unknown international eligibility criteria—requires verification that Nigerian applicants can compete before proceeding.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: ~$72,000 average (estimated from $3.6M total ÷ 50 recipients)
Type: fellowship
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-10 HUMAN_REQUIRED → INELIGIBLE · hygiene audit: misclassified postdoc/PhD/aggregator listing, not startup/fellowship fit

2026-07-09 HUMAN_REQUIRED → HUMAN_REQUIRED · Three sequential checks required: (1) Confirm the 2026 cycle is closed by visiting phrmafoundation.org directly and checking for any open application windows. (2) Determine whether a 2027 cycle will open and when (PhRMA Foundation typically opens applications September–November for the following year). (3) Contact the Foundation directly to ask whether independent researchers without US institutional affiliation are eligible—if a US academic host or collaborator (e.g., Kent Berridge at Michigan, Samuel Gershman at Harvard, or Nathaniel Daw at Princeton) would formally sponsor the application, eligibility may be achievable, but this arrangement must be confirmed and agreed upon before any application work begins.

2026-07-05 OPEN → HUMAN_REQUIRED · Three sequential checks required: (1) Confirm the 2026 cycle is closed by visiting phrmafoundation.org directly and checking for any open application windows. (2) Determine whether a 2027 cycle will open and when (PhRMA Foundation typically opens applications September–November for the following year). (3) Contact the Foundation directly to ask whether independent researchers without US institutional affiliation are eligible—if a US academic host or collaborator (e.g., Kent Berridge at Michigan, Samuel Gershman at Harvard, or Nathaniel Daw at Princeton) would formally sponsor the application, eligibility may be achievable, but this arrangement must be confirmed and agreed upon before any application work begins.